OncoLens

OncoLens

Private
Atlanta, GeorgiaHealthcare & Life Scienceshttps://oncolens.com

Last Round

Series B

Oct 24, 2024

Total Funding Raised

$24.6M

Momentum Score

75 /100

Company Overview

OncoLens is a healthcare technology company that provides an AI-driven, oncology-focused digital health platform that enhances cancer care through analytics and multidisciplinary collaboration tools.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Clinical Trials, Medical AI, Data Integration, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Data as a Service, Services & Consulting

AI Layer

Application

Keywords

tumor board softwarecancer care collaborationclinical trial matchingoncology AIvirtual tumor boardclinical decision supportoncology softwareprecision oncologyEMR integrationEHR integrationpatient cohort identificationreal-world evidenceRWEreal-world dataRWDgenomic data integrationcancer informaticsHIPAA compliance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OncoLens Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

OncoLens Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BOct 24, 2024
Series AJan 13, 2021
SeedMar 26, 2019

Key People

Founding team and executive leadership

Anju Mathew

CEO And Co-Founder

Founding Team

Todd Grant

Chief Financial Officer

Executive Team

OncoLens Investors

Notable investors and investment history

InvestorRounds
BIP CapitalSeries A, Seed, Series B
SeedtoB CapitalSeries A
Cross Border Impact VenturesSeries B
Atlanta Technology AngelsSeed
Martin VenturesSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 19, 2025

    Dr. Walter "Wally" Curran joins the Advisory Board.

  • May 19, 2025

    Dr. Joseph Kim joins the Advisory Board.

OncoLens Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OncoLens Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OncoLens's valuation, stock price, and market status.

Firmographic Details

HeadquartersAtlanta, Georgia
Employee Range31
Year Founded2017
Last FundingOct 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.